Since 1984, we have been developing innovative ways to assist hospital laboratories. In 1987, MEDTOX developed the first FDA 510(k)-cleared diagnostics drug-screening device. Since then, the company has received FDA 510(k)-clearance on dozens of individual drug-screening devices.
All MEDTOX devices are subject to an extensive internal QC/QA process, and their performance is measured through ongoing comparison with CAP UDS proficiency specimens.